Clinical Trials Browser

Radium-223 × Genitourinary × 30 days × Clear all

NCT04109729 2026-03-02

Rad2Nivo

Phase 1 Active not recruiting

Metastatic Castration-resistant Prostate Cancer

NCT03574571 2026-02-27

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Phase 3 Active not recruiting

Prostatic Neoplasms